Medisinsk forskning på cannabis
I dette arkivet finner du over 15 000 lenker til forskningsartikler og studier på cannabis planten. Listen er på engelsk, delt opp i medisinske lidelser og andre kategorier i alfabetisk rekkefølge.
NB! Sidene på hver bokstav kan laste tregt da tusenvis av linker lastes
C
CACHEXIA (9)
-
Nutritional Interventions for Cancer-induced Cachexia
-
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world
-
Clinical evaluation and optimal management of cancer cachexia
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Cannabis â therapy for the future?
-
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis
-
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome
-
Cachexia
-
A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9- tetrahydrocannabinol, elicits hyperphagia in rats
CAFFEINE and the ENDOCANNABINOID SYSTEM (5)
-
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors
-
Combined effects of THC and caffeine on working memory in rats
-
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Î9-tetrahydrocannabinol on spatial memory
-
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance
-
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
CANCER-ADENOCARCINOMA (4)
-
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists
-
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy
-
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
-
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
CANCER-BLADDER/URETHRAL (6)
-
TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer
-
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells
-
Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
-
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Menâs Health Study
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
CANCER-BONE (23)
-
Spinal and peripheral analgesic effects of the CB cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain
-
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss
-
The endocannabinoid system and cancer: therapeutic implication
-
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain
-
Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model
-
New targets, new drugs for metastatic bone pain: a new philosophy
-
Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice
-
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
-
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists
-
Antimetastatic activity of honokiol in osteosarcoma
-
Role of cannabinoid 2 receptor in the development of bone cancer pain
-
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain
-
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line
-
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models
-
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain
-
Involvement of PAR-4 in Cannabinoid-Dependent Sensitization of Osteosarcoma Cells to TRAIL-Induced Apoptosis
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2
-
The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells
-
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord
-
A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2
-
Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2
-
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma
CANCER-BREAST (57)
-
Anxiety Associated with Dying
-
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
-
A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
-
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Rasfarnesylation mediate antitumor effects of anandamide in human breast cancer cells
-
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)
-
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231 breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase/AKT and P38 pathways
-
The endocannabinoid system and cancer: therapeutic implication
-
Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion
-
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy
-
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis
-
The effect of CBD (BDS) botanical cannabinoid extraction on MCF-7 human breast carcinoma cells
-
L-α-lysophosphatidylinositol meets GPR55: a deadly relationship
-
Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis
-
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines
-
The CB2 receptor regulates osteoclast formation, breast cancer cell migration and osteoclast / tumour cell interaction via the PI3 Kinase/AKT pathway
-
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists
-
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
-
Cannabinoids: A new hope for breast cancer therapy?
-
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer
-
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDAMB-231 breast cancer cell migration
-
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Induction of the fatty acid 2-hydroxylase (FA2H) gene by â9-tetrahydrocannabinol in human breast cancer cells
-
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy
-
Inhibition Of Fatty Acid Amide Hydrolase Activates Nrf2 Signaling And Induces Heme Oxygenase 1 Transcription In Breast Cancer Cells
-
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OHTamoxifen
-
US Patent Application 20130059018 â PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER
-
Cannabinoids may be therapeutic in breast cancer
-
Role of cannabinoid and vanilloid receptors in invasion of human breast carcinoma cells
-
The effect of CBG (BDS) botanical cannabinoid extract on MCF-7 human breast carcinoma cells
-
Inflammatory signaling as a therapeutic target for the treatment of breast cancer-induced bone pain
-
Differential Modulation of Tumor Cell Proliferation and their Endocannabinoid System by Polyunsaturated Fatty Acids
-
Magnolol induces apoptosis in MCF-7 human breast cancer cells through G2/M phase arrest and caspase-independent pathway
-
Anandamide inhibits breast tumor-induced angiogenesis
-
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells
-
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
-
Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA-MB231 breast cancer cells
-
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
-
Targeting multiple cannabinoid antitumor pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer induced osteolysis
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against TripleNegative Breast Cancer
-
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer
-
Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2
-
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development
-
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
-
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer
-
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
-
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
-
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer
-
Delineating the molecular mechanisms of tamoxifenâs oncolytic actions in estrogen receptor-negative cancers
-
Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness
-
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
CANCER-CERVICAL (5)
-
Marijuana Use is Not Associated with Cervical Human Papillomavirus Natural History or Cervical Neoplasia in HIV-Seropositive or HIV-Seronegative Women
-
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
-
The evolving role of the endocannabinoid system in gynaecological cancer
-
Over-expression of cannabinoid receptor 2 induces the apoptosis of cervical carcinoma Caski cells
-
Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells
CANCER-CHOLANGIOCARCINOMA (6)
-
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling
-
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases
-
Recent advances in the regulation of cholangiocarcinoma growth
-
The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: antiinvasion activity at low concentration and apoptosis induction at high concentration
-
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
-
The novel cannabinoid receptor GPR55, inhibits cholangiocarcinoma growth
CANCER-COLON/COLORECTAL (40)
-
Effects of anandamide on polyamine levels and cell growth in human colon cancer cells
-
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids or the treatment of inflammatory diseases
-
Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability
-
The endogenous cannabinoid, anandamide, induces COX-2-dependent cell death in apoptosis-resistant colon cancer cells
-
Induction of p53-independent apoptosis by a novel synthetic hexahydrocannabinol analog is mediated via Sp1-dependent NSAID-activated gene-1 in colon cancer cells
-
Involvement of NSAID-activated gene-1 in a novel synthetic hexahydrocannabinol analogue-induced growth inhibition and apoptosis of colon cancer cells
-
Evaluation of the Cyclooxygenase Inhibiting Effects of Six Major Cannabinoids Isolated from Cannabis sativa
-
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent
-
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â 2011-09-14
-
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth
-
Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts
-
Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxiainducible factor-1α activation
-
The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model
-
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells
-
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
-
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms
-
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
-
The Cannabinoid WIN 55,212-2 Decreases Specificity Protein (Sp) Transcription Factors and the Oncogenic Cap Protein eIF4E in Colon Cancer Cells
-
Honokiol as a Radiosensitizing Agent for Colorectal cancers
-
US Patent Application 20130059018 â PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER
-
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
-
Stabilization of MDA-7/IL-24 for colon cancer therapy
-
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis derived non-psychotropic cannabinoid
-
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells
-
Physiological intestinal oxygen modulates the Caco-2 cell model and increases sensitivity to the phytocannabinoid cannabidiol
-
WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation
-
Potential therapeutic applications of cannabinoids in gastrointestinal and liver diseases: Focus on Î9-tetrahydrocannabinol pharmacology
-
Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population
-
Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms
-
Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines
-
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
-
Endocannabinoids and the Digestive Tract and Bladder in Health and Disease
-
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway
-
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives
-
Endocannabinoids in the gut
-
The gastrointestinal tract â a central organ of cannabinoid signaling in health and disease
-
Docosahexaenoyl Serotonin, an endogenously formed n-3 fatty acid-serotonin conjugate has anti-inflammatory properties by attenuating IL-23âIL-17 signalling in macrophages
CANCER-ENDOMETRIAL (4)
-
The Levels of the Endocannabinoid Receptor CB2 and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
Effect of anandamide on endometrial adenocarcinoma (Ishikawa) cell numbers: implications for endometrial cancer therapy
-
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism
CANCER-GASTRIC (8)
-
Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and c onsequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals
-
Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells
-
Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells
-
Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells
-
Antineoplastic Effect of WIN 55,212-2, a Cannabinoid Agonist, in a Murine Xenograft Model of Gastric Cancer
-
Simulation of Swansonâs Literature-Based Discovery: Anandamide Treatment Inhibits Growth of Gastric Cancer Cells In Vitro and In Silico
-
WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of Gastric Cancer Cells via COX-2 Signals
-
Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells
CANCER-GLIOMA/BRAIN CANCERS (45)
-
Cannabidiol Enhances the Inhibitory Effects of Î9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival
-
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas
-
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress
-
Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas
-
Synthesis of Novel Cannabinoid Ligands and Their Use as Anti-Glioma and AntiInflammatory Agents
-
Anti-tumoural effects of cannabinoid combinations â Patent TW201002315 (A) â2010-01-16
-
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas
-
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation
-
A combined preclinical therapy of cannabinoids and temozolomide against glioma
-
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
-
Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â 2011-09-14
-
Cannabidiol inhibits angiogenesis by multiple mechanisms
-
Alteration of endocannabinoid system in human gliomas
-
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
-
Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233
-
The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients
-
Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target
-
Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme
-
Influence of serum and albumin on the in vitro anandamide cytotoxicity toward C6 glioma cells assessed by the MTT cell viability assay: implications for the methodology of the MTT tests
-
Honokiol-induced apoptosis and autophagy in glioblastoma multiforme cells
-
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
-
Cannabinoid signaling in glioma cells
-
Regulation of cell proliferation by GPR55/cannabinoid receptors using (R,Râ)-4â-methoxy-1-naphthylfenoterol in rat C6 glioma cell line
-
Systematic review of the literature on clinical and experimental trials on the antitumor effects of cannabinoids in gliomas
-
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood Brain Barrier
-
The antitumor action of cannabinoids on glioma tumorigenesis
-
The Combination of Cannabidiol and Î9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model
-
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies
-
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patientsâ cells
-
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
-
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stemlike cells proliferation by inducing autophagy in a TRPV2-dependent manner
-
On the effects of CP 55-940 and other cannabinoid receptor agonists in C6 and U373 cell lines
-
Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma multiforme
-
Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells
-
Curcumin sensitizes human U-87 glioblastoma and MCF-7 breast cancer cells to the endocannabinoid reuptake inhibitor OMDM-2
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
-
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion
-
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system
-
Quantitative analyses of synergistic responses between cannabidiol and DNA-damaging agents on the proliferation and viability o glioblastoma and neural progenitor cells in culture
-
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (2016
CANCER-HEAD AND NECK (10)
-
Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium
-
The use of cannabinoids in chronic pain
-
The use of cannabinoids in chronic pain
-
Cannabis and the Lung: No More Smoking Gun?
-
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
-
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species
-
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patientsâ survival
-
Head and neck cancer among marijuana users: A meta-analysis of matched case-control studies
-
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
-
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy
CANCER-KIDNEY (6)
-
Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma
-
Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells
-
Cannabinoid CB(1) receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma
-
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics
-
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory
-
Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression
CANCER-LEUKEMIA (13)
-
Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS)
-
Cannabidiol induced a contrasting pro-apoptotic effect between freshly isolated and precultured human monocytes
-
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids
-
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation
-
Enhancing the Activity of Cannabidiol and Other Cannabinoids In Vitro Through Modifications to Drug Combinations and Treatment Schedules
-
A role for oleoylethanolamide in chronic lymphocytic leukemia
-
Synthesis of Tetrahydrohonokiol Derivates and Their Evaluation for Cytotoxic Activity against CCRF-CEM Leukemia, U251 Glioblastoma and HCT-116 Colon Cancer Cells.
-
Effect of Honokiol on Proliferation and Apoptosis in HL-60 Cells and Its Potential Mechanism
-
Cannabidiol for the Prevention of Graft-Versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
-
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation
-
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies?
CANCER-LIVER (19)
-
The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis
-
Recent advances in the understanding of the role of the endocannabinoid system in liver diseases
-
The effect of the activation of cannabinoid receptor on the proliferation and apoptosis of hepatoma HepG2 cells
-
Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells
-
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK dependent activation of autophagy
-
Cannabinoid receptor activation correlates with the pro-apoptotic action of the β2-adrenergic agonist, (R,Râ)-4-methoxy-1-naphthylfenoterol, in HepG2 hepatocarcinoma cells
-
Anti-proliferative effects of anandamide in human hepatocellular carcinoma cells
-
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry
-
Evaluation of Anti-invasion Effect of Cannabinoids on Human Hepatocarcinoma Cells
-
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
-
(R,Râ)-4â-methoxy-1-naphthylfenoterol Inhibits GPR55 signaling and the modulation of motility in human cancer cells
-
(R,Râ)-4â²-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility
-
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells
-
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells
-
[Corrigendum] Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells
-
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells
-
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis
-
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis
-
Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells
CANCER-LUNG (32)
-
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis
-
Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells
-
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
-
Effects of smoking cannabis on lung function
-
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis
-
PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis
-
Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1
-
Association Between Marijuana Exposure and Pulmonary Function Over 20 Years
-
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Nonsmall Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation
-
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
-
Effects of marijuana smoking on the lung
-
Cannabis and the Lung: No More Smoking Gun?
-
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors
-
Magnolol induces apoptosis via caspase-independent pathways in non-small cell lung cancer cells
-
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway
-
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells
-
Cannabinoids Increase Lung Cancer Cell Lysis By Lymphokine-Activated Killer Cells Via Upregulation of ICAM-1
-
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup
-
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men
-
How beneficial is vaping cannabis to respiratory health compared to smoking?
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4
-
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
-
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
-
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway
CANCER-LYMPHOMA (11)
-
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells
-
The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas
-
The expression of the peripheral cannabinoid receptor CB2 has no effect on clinical outcome in diffuse large B-cell lymphomas
-
Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism
-
Expression and functional relevance of cannabinoid receptor 1 in hodgkin lymphoma
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features
-
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features
-
Influence of rimonabant treatment on peripheral blood mononuclear cells flow cytometry analysis and gene expression profiling
-
The potential relevance of the endocannabinoid, 2-arachidonoylglycerol, in diffuse large B-cell lymphoma
-
High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana
CANCER-MELANOMA (16)
-
The antimitogenic effect of the cannabinoid receptor agonist WIN55212-2 on human melanoma cells is mediated by the membrane lipid raft
-
Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect
-
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
-
Revisiting CB1 Receptor as Drug Target in Human Melanoma
-
Cannabinoid receptor 2 is upregulated in melanoma
-
Anticancer activity of anandamide in human cutaneous melanoma cells
-
Calcium regulation by temperature-sensitive transient receptor potential channels in human uveal melanoma cells
-
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier
-
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target?
-
Honokiol inhibits melanoma stem cells by targeting notch signaling
-
Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway
-
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death
-
Differential role of cannabinoids in the pathogenesis of skin cancer
-
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells
-
Melanoma research in Hungary: promising results in a previously orphan tumor
-
Tumor-promoting effects of cannabinoid receptor type 1 in human melanoma cells
CANCER-MULTIPLE MYELOMA (7)
-
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy induced painful neuropathy
-
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
-
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption
-
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
-
Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration
-
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies?
-
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo
CANCER-NASOPHARYNGEAL (1)
CANCER-NEUROBLASTOMA (10)
-
Cancer â Childhood neuroblastoma complete remission
-
Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
-
Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth
-
â(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells
-
The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CBâ- and FAAH-independent mechanisms
-
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells
-
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells
-
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma
-
JWH-133, a Selective Cannabinoid CB2 Receptor Agonist, Exerts Toxic Effects on Neuroblastoma SH-SY5Y Cells
-
Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines
CANCER-ORAL (7)
-
Cannabinoids Inhibit Cellular Respiration of Human Oral Cancer Cells
-
Cannabinoids attenuate cancer pain and proliferation in a mouse model
-
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells
-
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges
-
Anti-proliferative effect of honokiol in oral squamous cancer through the regulation of specificity protein 1
-
Association of Marijuana Smoking with Oropharyngeal and Oral Tongue Cancers: Pooled Analysis from the INHANCE Consortium
-
Review of Various Herbal Supplements as Complementary Treatments for Oral Cancer
CANCER-OVARIAN (6)
-
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
-
Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis
-
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors
-
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis
-
The evolving role of the endocannabinoid system in gynaecological cancer
-
Why I chose to use cannabis
CANCER-PANCREATIC (6)
-
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
-
Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells
-
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells
-
(R,Râ)-4â²-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility
-
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
CANCER-PROSTATE (36)
-
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
-
The endocannabinoid system and cancer: therapeutic implication
-
Induction of apoptosis by cannabinoids in prostate and colon cancer cells is phosphatase dependent
-
Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells
-
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â2011-09-14
-
The endocannabinoid system in prostate cancer
-
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines
-
The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications
-
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells
-
Towards the use of non-psychoactive cannabinoids for prostate cancer
-
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer
-
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: proapoptotic effects and underlying mechanisms
-
Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
US Patent Application 20130059018 â PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER
-
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity
-
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells
-
Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations
-
Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray
-
Honokiol inhibits androgen receptor activity in prostate cancer cells
-
Cannabinoids as therapeutic agents in cancer: current status and future implications.
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
-
Proapoptotic effect of endocannabinoids in prostate cancer cells
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Cannabinoid Receptorâ2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and PâSelectin Activity.
-
Co-Localization of Alpha1-Adrenoceptors and GPR55: A Novel Prostate Cancer Paradigm?
-
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
-
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer
-
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
-
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells
-
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
-
A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells
CANCER-SKIN (10)
-
Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation
-
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
-
Chemopreventive effects of combination of honokiol and magnolol with α-santalol on skin cancer developments
-
Cyclooxygenase-2 regulates anandamide-induced endoplasmic reticulum stress in tumorigenic keratinocytes
-
Structure-dependent inhibitory effects of synthetic cannabinoids against 12-Otetradecanoylphorbol-13-acetate-induced inflammation and skin tumour promotion in mice
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
The effect of CBD, CBG and a combination of CBD plus CBG on Haccat human skin carcinoma cells
-
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides
-
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling
-
The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation
CANCER-SQUAMOUS CELL CARCINOMA (12)
-
Expression of cannabinoid receptor 2 in squamous cell carcinoma
-
Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells
-
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges
-
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
-
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species
-
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
-
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patientsâ survival
-
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanineinduced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
-
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells
-
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy
-
Medical Cannabis in the Palliation of Malignant WoundsâA Case Report
-
Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis
CANCER-VARIOUS/UNNAMED (136)
-
Antitumorigenic Effects of Cannabinoids beyond Apoptosis
-
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain
-
NEW USE FOR CANNABINOID-CONTAINING PLANT EXTRACTS Patent application number: 20100249223
-
US Patent Application 20100204312 â METHODS AND COMPOSITIONS FOR TREATING CANCER
-
Targeting the Endocannabinoid System for the Treatment of Cancer â A Practical View
-
Cannabis-derived substances in cancer therapyâan emerging anti-inflammatory role for the cannabinoids
-
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1
-
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
-
Arachidonoyl ethanolamide (AEA)-induced apoptosis is mediated by J-series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockade
-
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
-
Intrathecal Administration of the Cannabinoid 2 Receptor Agonist JWH015 Can Attenuate Cancer Pain and Decrease mRNA Expression of the 2B Subunit of N-Methyld-Aspartic Acid
-
The endocannabinoid system and cancer: therapeutic implication
-
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial
-
The intersection between cannabis and cancer in the United States
-
Phytocannabinoids for use in the treatment of cancer â Patent GB2478595 (A) â 2011-09-14
-
Update on the endocannabinoid system as an anticancer target
-
The endocannabinoid system in the cancer therapy: an overview
-
Cannabidiol inhibits angiogenesis by multiple mechanisms
-
Cannabinoid-associated cell death mechanisms in tumor models (Review)
-
Monoacylglycerol lipase â a target for drug development?
-
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
-
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth
-
Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids
-
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
-
The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world
-
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy
-
Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators
-
Towards the use of cannabinoids as antitumour agents
-
Modulating the endocannabinoid system in human health and disease: successes and failures
-
Autophagy triggered by magnolol derivative negatively regulates angiogenesis
-
Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis
-
Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
-
The endocannabinoid system, cannabinoids, and pain
-
An open-label extension study to investigate the long-term safety and tolerability of THC / CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics
-
A potential role for GPR55 in gastrointestinal functions
-
Therapeutic potential of monoacylglycerol lipase inhibitors
-
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers
-
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
-
Cannabidiol as potential anticancer drug
-
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care
-
Critical appraisal of the potential use of cannabinoids in cancer management
-
The Inhibitory Effects of Cannabidiol on Systemic Malignant Tumors
-
Therapeutic potential of cannabinoid medicines
-
Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells
-
The pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer action
-
The endocannabinoid signaling system in cancer
-
Cytotoxic effect of Efavirenz is selective against cancer cells and associated with the cannabinoid system
-
Preparation and characterization of Î9-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines
-
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1
-
Medicinal chemistry and pharmacology focused on cannabidiol, a major component of the fiber-type cannabis
-
Medical marijuana for cancer
-
Marijuana and Body Weight
-
Selected terpenoids from medicinal plants modulate endoplasmic reticulum stress in metabolic disorders
-
Clinical evaluation and optimal management of cancer cachexia
-
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
-
Target-Selective Phototherapy Using a Ligand-Based Photosensitizer for Type 2 Cannabinoid Receptor
-
The Neurobiology of Cancer Pain
-
Cannabinoids as therapeutic agents in cancer: current status and future implications
-
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β
-
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases
-
Report on Medical Cannabis Research History- What the Science Says
-
Is the Clinical Use of Cannabis by Oncology Patients Advisable?
-
The Role of Monoacylglycerol Lipase (MAGL) in the Cancer Progress
-
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
-
Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth
-
Characterization of HU-331 as a cannabinoid quinone inhibitor of topoisomerase II
-
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells
-
Use and medicalization of marihuana in cancer patients
-
The Neurobiology of Cancer Pain
-
Cannabis in cancer care
-
The use of cannabinoids as anticancer agents
-
Cannabis and Cannabinodsâfor health professionals (PDQ®)
-
Cannabis and Cannabinoids (PDQ®): Patient Version
-
PROGRESS REPORT Compassionate Use of Medical Cannabis Pilot Program Act July 1, 2014 through June 30, 2015
-
Plant derived substances with anti-cancer activity: from folklore to practice
-
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders
-
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy
-
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
-
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer
-
The evolving role of the endocannabinoid system in gynaecological cancer
-
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience
-
Î9 Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8
-
Anti-carcinogenic activity of anandamide on human glioma in vitro and in vivo
-
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science
-
New insights into antimetastatic and antiangiogenic effects of cannabinoids
-
Arachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: Role of cyclooxygenase-2 and novel J-series prostamides
-
Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice
-
Downstream effects of endocannabinoid on blood cells: implications for health and disease
-
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects
-
The Use of Styrene Maleic Acid Nanomicelles Encapsulating the Synthetic Cannabinoid Analog WIN55,212-2 for the Treatment of Cancer
-
A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients
-
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
-
Endocannabinoids and Cancer
-
Oncosuppressive functions of tribbles pseudokinase 3
-
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats
-
Cannabinoid-induced autophagy: protective or death role?
-
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
-
Delta(9)-tetrahydrocannabinol and cannabidiol as potential curative agents for cancer: A critical examination of the preclinical literature
-
Cannabis and cancer: reality or pipe dream?
-
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveal a Mechanism for Regulation of Tumor Progression
-
Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents
-
Endocannabinoids as Guardians of Metastasis
-
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
-
Cannabis and cancer: toward a new understanding
-
Cannabinoid pharmacology in cancer research: A new hope for cancer patients?
-
Integrating cannabis into clinical cancer care
-
Anticancer mechanisms of cannabinoids
-
Endocannabinoid system as a regulator of tumor cell malignancy â biological pathways and clinical significance
-
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
-
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
-
A userâs guide to cannabinoid therapies in oncology
-
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
-
Cannabis and Cannabinoids (PDQ®)Health Professional Version
-
Using Medical Cannabis in an Oncology Practice
-
Using Medical Cannabis in an Oncology Practice
-
Cannabis and Cannabinoids
-
Ligands for cannabinoid receptors, promising anticancer agents
-
Role of the lysophosphatidylinositol/GPR55 axis in cancer
-
Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome
-
Antitumorigenic targets of cannabinoids â current status and implications
-
Delineating the molecular mechanisms of tamoxifenâs oncolytic actions in estrogen receptor-negative cancers
-
Influence of Biomechanical Properties and Cannabinoids on Tumor Invasion
-
The Use of Medical Marijuana in Cancer
-
Phytochemicals as adjunctive with conventional anticancer therapies
-
Pediatric oncology providers and use of medical marijuana in children with cancer
-
Endocannabionoid System in Neurological Disorders
-
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence
-
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation
-
N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation
-
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review)
-
Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa
-
State of the evidence: Cannabinoids and cancer pain-A systematic review
-
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion
-
Cannabinoids â a new weapon against cancer?
-
Medical Cannabis in the Palliation of Malignant WoundsâA Case Report
-
Expertsâ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study.
CANCERâTESTICULAR (1)
CANNABINOID HYPEREMESIS SYNDROME (62)
-
Cannabinoid hyperemesis. (# 1)
-
Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation
-
Cannabinoid-Induced Hyperemesis: A ConundrumâFrom Clinical Recognition to Basic Science Mechanisms
-
The cannabis hyperemesis syndrome characterized by persistent nausea and vomiting, abdominal pain, and compulsive bathing associated with chronic marijuana use: a report of eight cases in the United States
-
A man in his 30s with recurrent vomiting and abdominal pain relieved by hot showers
-
Cannabinoid hyperemesis syndrome as the underlying cause of intractable nausea and vomiting
-
Cannabis Hyperemesis Syndrome (# 1)
-
Cannabis Hyperemesis Syndrome (# 2)
-
Image of the month. Skin discoloration from compulsive bathing in a patient with hyperemesis syndrome
-
Cannabis Hyperemesis Syndrome (# 3)
-
Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance
-
Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm
-
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy
-
Pediatric cannabinoid hyperemesis: two cases
-
Hyperemesis and a High Water Bill
-
Cannabinoid hyperemesis syndrome: case report of a paradoxical reaction with heavy marijuana use
-
Cannabinoid hyperemesis: a case series of 98 patients
-
Cyclic vomiting syndrome and functional vomiting in adults: association with cannabinoid use in males
-
CannabisâA Valuable Drug That Deserves Better Treatment
-
Association of Marijuana Use and Cyclic Vomiting Syndrome
-
Cannabinoid hyperemesis. (# 4)
-
A hot bath to calm what ails you â the Cannabis Hyperemesis Syndrome
-
Cannabinoid Hyperemesis Syndrome: A Case Series and Review of Previous Reports
-
Spicing Up the Differential for Cyclic Vomiting: A Case of Synthetic-Cannabinoid Induced Hyperemesis Syndrome (CH)
-
Cannabinoid Hyperemesis Syndrome
-
Compulsive showering and marijuana use â the cannabis hyperemisis syndrome
-
Cannabinoid Hyper-emesis Syndrome: An Enigma
-
Cannabinoid hyperemesis syndrome with extreme hydrophilia
-
A Case of Cannabinoid Hyperemesis Syndrome Caused by Synthetic Cannabinoids
-
Haloperidol for treatment of cannabinoid hyperemesis syndrome
-
Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome
-
A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid
-
Mid-ventricular Variant Takotsubo Cardiomyopathy Associated with Cannabinoid Hyperemesis Syndrome: A Case Report
-
Cannabinoid hyperemesis should be recognised as an effect of chronic cannabis abuse
-
Case of cannabinoid hyperemesis syndrome with long-term follow-up
-
Cannabinoid Hyperemesis Syndrome: A Case Report and Review of Pathophysiology
-
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS)
-
Cannabinoid Hyperemesis Syndrome: An Emerging Drug-Induced Disease
-
No opiates against cannabis hyperemesis syndrome
-
Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome
-
Cannabinoid hyperemesis syndrome: About 6 cases
-
Cyclic Vomiting Presentations Following Marijuana Liberalization in Colorado
-
Cannabinoid Hyperemesis Syndrome: Descriptive Overview of an Under-Recognized Diagnosis
-
Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic
-
Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect
-
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire
-
A non-classical cannabinoid syndrome
-
Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review
-
Novel case of synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure
-
Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury
-
Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting
-
Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting
-
Cannabinoid Hyperemesis Syndrome: A Case Report of Cyclic Severe Hyperemesis and Abdominal Pain with Long-Term Cannabis Use
-
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis Enigma
-
Cannabinoid hyperemesis syndrome masquerading as an eating disorder
-
Cannabinoid hyperemesis syndrome and the onset of a manic episode
-
Cannabis Hyperemesis Syndrome in the Emergency Department: How Can a Specialized Addiction Team Be Useful? A Pilot Study
-
Hypophosphatemia in Users of Cannabis
-
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline.
-
Role of cannabis in digestive disorders
-
Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review
-
Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
CARPAL TUNNEL SYNDROME (2)
CATATONIA (4)
-
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report
-
Could spice drugs induce psychosis with abnormal movements similar to catatonia?
-
Catatonia and Cannabis Withdrawal: a case report
-
Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis
CELIAC DISEASE (3)
CEREBRAL PALSY (1)
CHEMICAL COMPOSITION (114)
-
Cannabinoid and Terpenoid Reference Guide
-
Î9-Tetrahydrocannabinol content in cannabis samples seized in Novi Sad during 2008
-
In silicio expression analysis of PKS genes isolated from Cannabis sativa L
-
QUALITY OF HEMP SEED OIL DEPENDING ON ITS OBTAINING
-
Stable isotope models to predict geographic origin and cultivation conditions of marijuana
-
Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes
-
Assessment of the Genetic Stability of Micropropagated Plants of Cannabis sativa by ISSR Markers
-
The results of an experimental indoor hydroponic Cannabis growing study, using the âScreen of Greenâ (ScrOG) method-Yield, tetrahydrocannabinol (THC) and DNA analysis
-
Variation in Î9-THC and other Cannabinoids Content in Field Grown Cannabis sativa L During Different Stages of Growth
-
Cannabis as a Unique Functional Food
-
How Accurate is Potency Testing?
-
Changes of photosynthesis-related parameters and productivity of Cannabis sativa under different nitrogen supply
-
Influence of agroclimatic conditions on content of main cannabinoids in industrial hemp (Cannabis sativa L)
-
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail
-
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
-
Heterogeneity in the composition of marijuana seized in California
-
How hemp got high
-
Isolation and Characterization of Edestin from Cheungsam Hempseed
-
Characteristics of cannabinoids composition of Cannabis plants grown in Northern Thailand and its forensic application
-
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
-
Bioactive Prenylogous Cannabinoid from Fiber Hemp (Cannabis sativa)
-
Cadmium Tolerance and Bioaccumulation of 18 Hemp Accessions
-
Cannabinoids: occurrence and medicinal chemistry
-
Cannabis profiling based on its elemental compositionâis it possible?
-
Variations in Photosynthesis, Transpiration, Water Use and Cannabinoid Contents in Field Grown Drug Type Varieties of Cannabis sativa L.
-
In vitro Germplasm Conservation of High THC Yielding Elite Clones of Cannabis sativa L. under Slow Growth Conditions
-
Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides
-
Isolation and characterization of some phytochemicals from Indian traditional plants
-
The hexanoyl-CoA precursor for cannabinoid biosynthesis is formed by an acylactivating enzyme in Cannabis sativa trichomes
-
Terpenoid biosynthesis in trichomesâcurrent status and future opportunities
-
Hemp Biology â Industrial Hemp vs. Marijuana
-
Hemp Species
-
Cannabis Strains: Do Cannabis Strains Differ?
-
Cannabis Genome Uncloaked: Commentary on the Scientific Implications
-
Cannabis Genome Uncloaked: Commentary on the Scientific Implications
-
Is todayâs marijuana more potent simply because itâs fresher?
-
Proteomic profiling of hempseed proteins from Cheungsam
-
Cannabis â from cultivar to chemovar
-
Heat Exposure of Cannabis sativa Extracts Affects the Pharmacokinetic and Metabolic Profile in Healthy Male Subjects
-
Chemiluminescence detection of cannabinoids and related compounds with acidic potassium permanganate
-
Structure and Function of Î1-Tetrahydrocannabinolic Acid (THCA) Synthase, the Enzyme Controlling the Psychoactivity of Cannabis sativa
-
Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR
-
Studies on the Optimization of Agrotechniques to Maximize the Productivity of Two Cannabis Chemotypes Cultivated to Produce Medicinal Grade Plant Material
-
Cannabis, a complex plant: different compounds and different effects on individuals
-
In planta imaging of Î9-tetrahydrocannabinolic acid in Cannabis sativa L. with hyperspectral coherent anti-Stokes Raman scattering microscopy
-
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
-
Early Phenylpropanoid Biosynthetic Steps in Cannabis sativa: Link between Genes and Metabolites
-
Chemical profiling of different hashish seizures by gas chromatography-mass spectrometry and statistical methodology: a case report
-
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants
-
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands
-
Biotransformation of cannabinoids by a cell suspension culture of Cannabis sativa L
-
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK
-
LCMS Spectral Evidence of the Occurrence of Cannabinoid in Cannabis sativa Cell Cultures
-
Ethephon application stimulates cannabinoids and plastidic terpenoids production in Cannabis sativa at flowering stage
-
Study of leaf metabolome modifications induced by UV-C radiations in representative Vitis, Cissus and Cannabis species by LC-MS based metabolomics and antioxidant assays
-
Affinity comparison of different THCA synthase to CBGA using modeling computational approaches
-
Influence of mevinolin on chloroplast terpenoids in Cannabis sativa
-
Targeted mutation of Î12 and Î15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil
-
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases
-
Amber is Bad ?